Showing results (171-180 of 195) with videos related to
Sort By:
Pageof 20
Journal of the Cardiometabolic Syndrome|December 2, 2008
Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) studyRobert A Phillips, Vivian Fonseca, Richard E Katholi, et al.The American Journal of Medicine|July 3, 2007
Body weight changes with beta-blocker use: results from GEMINIFranz H Messerli, David S H Bell, Vivian Fonseca, et al.Frontiers in Endocrinology|November 12, 2024
A genome-wide association study identifies genetic determinants of hemoglobin glycation index with implications across sex and ethnicityJohn S House, Joseph H Breeyear, Farida S Akhtari, et al.Diabetes Care|December 29, 2006
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes AssociationJohn B Buse, Henry N Ginsberg, George L Bakris, et al.Circulation|December 29, 2006
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes AssociationJohn B Buse, Henry N Ginsberg, George L Bakris, et al.Obesity (Silver Spring, Md.)|August 8, 2023
Initial weight loss and early intervention adherence predict long-term weight loss during the Promoting Successful Weight Loss in Primary Care in Louisiana lifestyle interventionChristoph Höchsmann, Corby K Martin, John W Apolzan, et al.Circulation|February 9, 2021
Effects of a 2-Year Primary Care Lifestyle Intervention on Cardiometabolic Risk Factors: A Cluster-Randomized TrialChristoph Höchsmann, James L Dorling, Corby K Martin, et al.Journal of the American Heart Association|April 26, 2019
PCSK9 Inhibitor Use in the Real World: Data From the National Patient-Centered Research NetworkAlanna M Chamberlain, Yan Gong, Kathryn McAuliffe Shaw, et al.Journal of the American College of Cardiology|August 14, 2024
Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 DiabetesDaniel Edmonston, Hillary Mulder, Elizabeth Lydon, et al.Metabolic Syndrome and Related Disorders|March 29, 2008
Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes in relation to the metabolic syndromeAndrew J Drexler, Richard W Nesto, Martin J Abrahamson, et al.Pageof 20